62934 Body Mass Index and Weight as Cardiometabolic Outcomes in Pediatric Patients With Moderate-to-Severe Plaque Psoriasis Treated With Apremilast: 16-Week Results From the SPROUT Randomized Controlled Trial
20251 citationsJournal Article
Field-Weighted Citation Impact: 0.81
62934 Body Mass Index and Weight as Cardiometabolic Outcomes in Pediatric Patients With Moderate-to-Severe Plaque Psoriasis Treated With Apremilast: 16-Week Results From the SPROUT Randomized Controlled Trial | Researchclopedia